We observed that NSUN5 hypermethylation was associated with increased overall survival (OS) in all glioma grades in the TCGA cohort [log-rank; P < 10−5; hazard ratio (HR) = 5.17, 95% CI = 2.78–9.61] (Fig. 7c). This evidence concerns the gene NSUN5 and central nervous system cancer.